Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

THE TRUTH ABOUT: Stephane bancel - The Untold Story

Moderna takes swipe at Trump as it opens new UK factory: ‘A country that still believes in vaccination’

New opening comes amid a rise in anti-vax attitudes within the Trump administration

The Independent UK

Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles

Moderna Inc. (NASDAQ:MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.

Benzinga

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

Moderna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna Stock Plummets 16% After £819.59M Guidance Cut Over Respiratory Vaccine Flop

Moderna is expediting its cost-cutting program and rolling back R&D amid a drop in vaccination rates and low revenues from a new vaccine.

International Business Times UK

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020.

Latin Times

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.

International Business Times

Moderna's CEO shares what it was like to leap from pre-revenue startup to Fortune 500 company

The COVID-19 vaccine turned Moderna into a household name. What's next for the company?

Fortune

Read news from The Economist, FT, and more,
with one subscription

Senators press Moderna CEO on COVID-19 vaccine price hike

Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price

The Independent UK

Lisa Jarvis: Cancer vaccine hunt makes progress, finally

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after decades of failures, researchers are finally figuring out the right way to design a vaccine that can teach immune cells how to recognize and combat tumors.

Tribune News Service

Moderna jab ‘to protect through the winter’ after positive new results

The main Covid-19 booster offers good protection for at least three months.

The Independent UK

Top Financial Stories Wednesday, September 14: Multiple Antitrust Setbacks For Google, Bitcoin Crashes, Visa Finds New Gun Control System Ineffective And More…

Reuters

Benzinga

Full details of next Covid booster rollout -and Omicron jab will be used

The Government has confirmed who will get another Covid injection and says new vaccine will be used

Wales Online

‘Next generation’ Covid booster jab to be offered to adults over 50 from autumn

Health Secretary Steve Barclay has said the vaccine will be part of the autumn booster programme.

The Independent UK

New covid jag approved by UK to specifically target Omicron will be fourth vaccine

Moderna’s chief medical officer, Dr Paul Burton, previously said that the new jag can boost a person’s antibodies to such high levels that it may only be needed once per year.

Daily Record

Get all your
news in one place.

100's of premium titles.
One news app.

Manchester Evening News

New Moderna vaccine to target two Covid strains in one dose

The UK has become the first country to approve the new booster, which is said will help protect people from Covid over the winter

The National (Scotland)

'Next generation' Covid jab approved in UK for use in adults

A new coronavirus booster jab has been approved for use in adults.

Daily Mirror

UK becomes first country to approve new Covid jab specifically targeting Omicron

Moderna's chief medical officer, Dr Paul Burton, previously said that the new jab can boost a person's antibodies to such high levels that it may only be needed annually

Evening Standard

First Covid vaccine that targets two variants approved in UK

The ‘next generation’ Moderna jab may only need to be administered once a year

Get all your
news in one place.

100's of premium titles.
One news app.

Wales Online

Once-a-year Covid jab approved for use in adults in UK

The new Moderna vaccine could put an end to three or four injections a year - and fights Omicron

The Independent UK

‘Next generation’ Moderna coronavirus booster jab approved for use in UK adults

The jab is the first to target two strains of Covid-19.

Benzinga

Moderna To establish New Vaccine Facility In Britain

Moderna Inc (NASDAQ:MRNA) announced an agreement with the United Kingdom government to establish an mRNA Innovation and Technology Center in the U.K. Additionally, Moderna plans to expand its presence in the U.K. through investments in R&D activities. Moderna is collaborating with the National Institute for Health Research on a Phase 3 study…

Benzinga

Time 100 Most Influential List Includes 10 Connected To Public Companies Such As Tim Cook, Andy Jassy And Joe Rogan

The annual Time 100 Most Influential People list for 2022 contains names such as U.S. President Joe Biden, Ukrainian President Volodymyr Zelenskyy and Chinese President Xi Jinping. The list also has several CEOs and names connected to public companies.

Benzinga

Moderna Says COVID-19 Booster To Be Ready By August, But Dicey If Omicron-Specific Needed: Reuters

Moderna Inc's (NASDAQ: MRNA) CEO, Stephane Bancel, told Reuters that an

Evening Standard

Covid booster will be needed in autumn, says Moderna chief executive Stephane Bancel

Another Covid booster vaccine will be needed by autumn, the chief executive of Moderna has said.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.